🧪 Researchers found crucial metabolic pathways affecting CHO cell performance during cultures.
📈 Their hierarchical approach revealed 109 metabolites, enhancing bioprocess insights.
🔬 This method can apply broadly to different data structures, potentially making therapeutics safer and more affordable.
Introduction:
The article discusses a novel analytical approach employed by researchers to enhance the efficiency of Chinese hamster ovary (CHO) cells used in biopharmaceuticals. With an increasing reliance on CHO cells for biologics production, there is a significant need to optimize cell productivity. The focus is on metabolite variations that correlate with cell efficiency, which the researchers aim to leverage for improving protein production processes.
- CHO cells are critical in the production of biologics, having been used for 89% of all approved biologic drugs from 2018 to 2022.
- To enhance productivity, optimizing both viable cell density and specific productivity is necessary.
- A novel method developed by the team at Umeå University and Sartorius Stedim Biotech addresses time dependencies in bioprocess data to identify significant metabolites related to process variables.
- The study analyzed the extracellular metabolome of 11 CHO clones, providing insights into the importance of the citrate cycle for cell productivity.
- The researchers proposed a hierarchical modeling approach that utilizes orthogonal partial least squares regression to identify metabolite-process relationships more accurately across varying time points.
Conclusion:
The findings reveal critical metabolites that can enhance CHO cell productivity, suggesting that their identification may lead to safer and more cost-effective therapeutic production. The proposed method, broadly applicable beyond metabolomics, could facilitate improvements across various biological research areas, underscoring its potential impact on the future of bioprocessing.
